v3.25.1
Business Segments and Geographic Information
 6 Months Ended
Mar. 29, 2025
Segment Reporting [Abstract]  
Business Segments and Geographic Information Business Segments and Geographic Information
The Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges (such as intangible asset amortization expense, and goodwill and intangible asset impairment charges), transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.
Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and six months ended March 29, 2025 and March 30, 2024. Segment information is as follows:

 Three Months EndedSix Months Ended
 March 29,
2025		March 30,
2024		March 29,
2025		March 30,
2024
Total revenues:
Diagnostics$453.6 $450.1 $924.2 $897.9 
Breast Health356.2 384.6 725.2 762.3 
GYN Surgical162.5 156.0 328.9 318.2 
Skeletal Health33.0 27.1 48.8 52.5 
$1,005.3 $1,017.8 $2,027.1 $2,030.9 
Income (loss) from operations:
Diagnostics$19.5 $71.1 $138.4 $120.5 
Breast Health95.7 91.7 163.2 193.8 
GYN Surgical(124.7)44.3 (78.1)87.6 
Skeletal Health2.5 3.3 (0.7)6.7 
$(7.0)$210.4 $222.8 $408.6 
Depreciation and amortization:
Diagnostics$48.5 $51.5 $97.1 $117.4 
Breast Health12.1 10.0 25.3 20.3 
GYN Surgical15.4 12.1 27.4 24.1 
Skeletal Health0.2 0.1 0.4 0.3 
$76.2 $73.7 $150.2 $162.1 
Capital expenditures:
Diagnostics$26.7 $19.8 $44.5 $44.0 
Breast Health3.0 5.4 11.8 14.7 
GYN Surgical9.2 2.5 12.9 6.7 
Skeletal Health— 0.3 — 0.4 
Corporate1.4 — 2.6 0.2 
$40.3 $28.0 $71.8 $66.0 
 
March 29,
2025		September 28,
2024
Identifiable assets:
Diagnostics$2,301.5 $2,431.3 
Breast Health1,565.2 1,588.9 
GYN Surgical1,649.3 1,419.9 
Skeletal Health36.6 48.3 
Corporate2,992.5 3,667.6 
$8,545.1 $9,156.0 

The Company had no customers that represented greater than 10% of consolidated revenues during the three and six months ended March 29, 2025 and March 30, 2024.

The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company’s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands. The Company’s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The “Rest of World” designation includes Canada, Latin America and the Middle East.
Revenues by geography as a percentage of total revenues were as follows:
 
 Three Months EndedSix Months Ended
 March 29,
2025		March 30,
2024		March 29,
2025		March 30,
2024
United States74.1 %74.6 %74.1 %74.5 %
Europe14.6 %13.5 %14.6 %13.8 %
Asia-Pacific5.9 %6.3 %5.9 %6.3 %
Rest of World5.4 %5.6 %5.4 %5.4 %
100.0 %100.0 %100.0 %100.0 %